Ronald Fogel
Gastroenterology · Chesterfield, MINPI 1588641633
Payments from drug & device makers
Across 2,110 payments — averaging $2429.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$890K
- AbbVie$730K
- Takeda Pharmaceuticals U.S.A., Inc.$617K
- Eli Lilly$457K
- Gilead$442K
- Janssen Research & Development, LLC$435K
- plus $1.6M from 29 others
Across 60 payments — averaging $5981.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Celltrion, Inc.$205K
- AbbVie$138K
- Eli Lilly$14K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Teva Pharmaceuticals USA, Inc.$120
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,126,861 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.
Other gastroenterology in Chesterfield
- Allan CoatesWyoming$5.9M
- Stuart GordonDetroit$4.3M
- Jeffery BerinsteinAnn Arbor$3.3M
- Najm SoofiYpsilanti$2.6M
- Peter HigginsAnn Arbor$2.4M
- Partha NandiTroy$1.4M
- Frederick AskariAnn Arbor$1.4M
- Reena SalgiaDetroit$1.3M
- Kimberly BrownDetroit$1.1M
- John WeberTroy$969K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.